The reexpression of MELK in TNBC, as opposed to normal tissues, is hypothesized to be driven by these genetic changes that reactivate embryonic pathways involved in cell cycle regulation and survival, crucial for cancer cell proliferation and resistance to apoptosis. The gene discussed is MELK; the disease is cancer.